Last quarter (Q2 2022), Quantum Genomics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Quantum Genomics's net income was $―. See Quantum Genomics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ ―	$ 116.21K	$ 1.20M	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	$ ―	$ 18.46M	$ 1.00M	$ 88.94K	$ 301.31K	$ 773.49K
Gross Profit	$ ―	$ -18.34M	$ 198.60K	$ -88.94K	$ -301.31K	$ -773.49K
Operating Expense	$ ―	$ 836.93K	$ 14.06M	$ 10.67M	$ 13.20M	$ 9.52M
Operating Income	$ ―	$ -19.18M	$ -13.86M	$ -10.76M	$ -13.50M	$ -10.29M
Net Non Operating Interest Income Expense	$ ―	$ -8.42K	$ -5.09K	$ 10.85K	$ 10.47K	$ -65.65K
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ -19.18M	$ -13.86M	$ -10.75M	$ -13.49M	$ -10.36M
Tax Provision	$ ―	$ -2.66M	$ -2.15M	$ -1.55M	$ -1.46M	$ -1.15M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -16.56M	$ -11.54M	$ -9.08M	$ -11.99M	$ -9.38M
Basic EPS	$ ―	$ -0.61	$ -0.43	$ -0.50	$ -0.76	$ -0.85
Diluted EPS	$ ―	$ -0.61	$ -0.43	$ -0.50	$ -0.76	$ -0.85
Basic Average Shares	$ ―	$ 27.35M	$ 26.71M	$ 18.07M	$ 15.78M	$ 10.99M
Diluted Average Shares	$ ―	$ 27.35M	$ 26.71M	$ 18.07M	$ 15.78M	$ 10.99M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ 19.29M	$ 15.06M	$ 10.76M	$ 13.50M	$ 10.29M
Net Income From Continuing And Discontinued Operation	$ ―	$ -16.52M	$ -11.72M	$ -9.20M	$ -12.04M	$ -9.21M
Normalized Income	$ ―	$ -16.52M	$ -11.72M	$ -9.20M	$ -12.04M	$ -9.21M
Interest Expense	$ ―	$ 13.35K	$ ―	$ ―	$ ―	$ ―
EBIT	$ ―	$ -19.17M	$ -13.86M	$ -10.76M	$ -13.50M	$ -10.29M
EBITDA	$ ―	$ -18.91M	$ -13.69M	$ -10.71M	$ -13.49M	$ -10.26M

Currency in USD

Quantum Genomics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing